B01AB04 - Dalteparin |
Not porphyrinogenic |
NP |
Rationale
Glycosaminoglycan. Non-CYP dependent metabolism.
Chemical description
(To be edited, initial data ST OCT 04) Antitrombotic low-molecular glycosaminoglycan. C.Andersson; patient reports: tolerated (n=1). Used in Swedish porphyria ward.
IPNet drug reports
Uneventful use reported in 2 patients with acute porphyria.
Similar drugs
© NAPOS 2024